Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 4;15(21):4325.
doi: 10.3390/polym15214325.

Synthesis and Characterization of Polymer-Based Membranes for Methotrexate Drug Delivery

Affiliations

Synthesis and Characterization of Polymer-Based Membranes for Methotrexate Drug Delivery

Ionela-Amalia Bradu et al. Polymers (Basel). .

Abstract

Methotrexate or amethopterin or 4-amino-N10-methyl pteroylglutamic acid is used for treating autoimmune diseases, as well as certain malignancies. Drug delivery systems, which are based on biopolymers, can be developed to improve the therapeutic and pharmacological properties of topically administered drugs. Biopolymers improve the therapeutic effect of drugs, mainly by improving their biodistribution and modulating drug release. This study presents the synthesis of membranes based on anionic polysaccharides and cationic polysaccharides for transdermal delivery of the active ingredient methotrexate, as well as a compatibility study between methotrexate and each of the components used in the prepared membranes. The obtained membranes based on different marine polysaccharides, namely κ-carrageenan and chitosan, for the release of the active ingredient methotrexate were characterized using techniques such as TG, FTIR, UV-Vis spectrophotometry, FTIR microscopy, water absorption capacity, water vapor permeability, and biodegradation rate. Following the studies, the membranes suitable for the transdermal release of the active substance were validated.

Keywords: drug delivery; membranes; methotrexate; polymers; synthesis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Chemical structure of MTX.
Figure 2
Figure 2
FTIR spectrum of Methotrexate.
Figure 3
Figure 3
FT-IR spectra of carrageenan-based membranes: MTX; CarGPVPMTX; CarGPVP; CarGPVAMTX; CarGPVA; CarGMTX; CarG; (Legend: Car–k-carrageenan; G–glycerol; PVA–polyvinyl alcohol; PVP–polyvinylpirrolydone, MTX–methotrexate).
Figure 4
Figure 4
FT-IR spectra of chitosan-based membranes–MTX; ChiGPVPMTX; ChiGPVP; ChiGPVAMTX; ChiGPVA; ChiGMTX; ChiG (Legend: Chi–chitosan; G–glycerol; PVA–polyvinyl alcohol; PVP–polyvinylpirrolydone; MTX–methotrexate).
Figure 5
Figure 5
TG (a) and DTG (b) curves of Car-based membranes: CarGPVP(−); CarGPVPMTX (−); CarG (−); CarGMTX (−); CarGPVA (−); CarGPVAMTX (−) (Legend: Car–k-carrageenan; G–glycerol; PVA–polyvinyl alcohol; PVP–polyvinylpirrolydone; MTX–methotrexate).
Figure 6
Figure 6
TG (a) and DTG (b) curves of Chi-based membranes: ChiGPVP (−); ChiGPVPMTX (−); ChiGMTX (−); ChiG (−); ChiGPVA (−); ChiGPVAMTX (−) (Legend: Chi–chitosan; G–glycerol; PVA–polyvinyl alcohol; PVP–polyvinylpirrolydone; MTX–methotrexate).
Figure 7
Figure 7
UV–VIS spectrum of MTX (−), CarGPVAMTX(−), and CarGPVPMTX (−) (Legend: Car–k−carrageenan; G–glycerol; PVA–polyvinyl alcohol; PVP–polyvinylpirrolydone; MTX–methotrexate).
Figure 8
Figure 8
UV–VIS spectrum of MTX (−), ChiGPVAMTX (−), and ChiGPVPMTX (−) (Legend: Chi–chitosan; G–glycerol; PVA–polyvinyl alcohol; PVP–polyvinylpirrolydone; MTX–methotrexate).
Figure 9
Figure 9
Appearance of (a) CarGPVAMTX; (b) CarGPVPMTX; (c) ChiGPVAMTX; (d) ChiGPVPMTX (Legend: Car–k-carrageenan; Chi–chitosan; G–glycerol; PVA–polyvinyl alcohol; PVP–polyvinylpirrolydone; MTX–methotrexate).
Figure 10
Figure 10
Degradation of membranes in lysozyme at 37 °C (CarGPVPMTX (−), CarGPVAMTX (−), ChiGPVPMTX (−), ChiGPVAMTX (−)) (Legend: Cark-carrageenan; Chichitosan; Gglycerol; PVApolyvinyl alcohol; PVPpolyvinylpirrolydone; MTXmethotrexate).

References

    1. Kunduru K.R., Basu A., Domb A. Encyclopedia of Polymer Science and Technology. 4th ed. John Wiley & Sons; Hoboken, NJ, USA: 2016. Biodegradable Polymers: Medical Applications; pp. 1–22.
    1. Pacheco-Quito E.M., Ruiz-Caro R., Veiga M.D. Carrageenan: Drug Delivery Systems and Other Biomedical Applications. Mar. Drugs. 2020;18:583. doi: 10.3390/md18110583. - DOI - PMC - PubMed
    1. Zhang J., Ma S., Liu H., Geng H., Lu X., Zhang X., Li H., Gao C., Zhag X., Gao P. Guided bone regeneration with asymmetric collagen-chitosan membranes containing aspirin- loaded chitosan nanoparticles. Int. J. Nanomed. 2017;12:8855–8866. doi: 10.2147/IJN.S148179. - DOI - PMC - PubMed
    1. García M.C. Engineering of Biomaterials for Drug Delivery Systems. Woodhead Publishing; Sawston, UK: 2018. Drug delivery systems based on nonimmunogenic biopolymers; pp. 317–344. - DOI
    1. Baranwal J., Barse B., Fais A., Delogu G.L., Kumar A. Biopolymer: A Sustainable Material for Food and Medical Applications. Polymers. 2022;14:983. doi: 10.3390/polym14050983. - DOI - PMC - PubMed

LinkOut - more resources